000935 四川双马
已收盘 05-08 15:00:00
资讯
新帖
简况
四川双马：公司连续流加氢技术平台正建设中
证券之星 · 05-08 11:33
四川双马：公司连续流加氢技术平台正建设中
四川双马（000935）披露2025年年度报告，4月28日股价下跌1.85%
证券之星 · 04-28
四川双马（000935）披露2025年年度报告，4月28日股价下跌1.85%
四川双马(000935.SZ)发布一季度业绩，归母净利润5879.61万元，同比下降49.55%
智通财经 · 04-28
四川双马(000935.SZ)发布一季度业绩，归母净利润5879.61万元，同比下降49.55%
股市必读：四川双马（000935）4月17日董秘有最新回复
证券之星 · 04-20
股市必读：四川双马（000935）4月17日董秘有最新回复
国金证券：给予四川双马买入评级
证券之星 · 03-29
国金证券：给予四川双马买入评级
股市必读：3月26日四川双马发生1笔大宗交易 成交金额1896.04万元
证券之星 · 03-27
股市必读：3月26日四川双马发生1笔大宗交易 成交金额1896.04万元
3月25日四川双马涨5.83%，华夏价值精选混合A基金重仓该股
证券之星 · 03-25
3月25日四川双马涨5.83%，华夏价值精选混合A基金重仓该股
3月23日四川双马跌5.83%，华夏价值精选混合A基金重仓该股
证券之星 · 03-23
3月23日四川双马跌5.83%，华夏价值精选混合A基金重仓该股
四川双马：本次股份转让正在按程序推进中
证券之星 · 03-19
四川双马：本次股份转让正在按程序推进中
四川双马：公司高度重视市值管理工作，始终将提升内在价值作为核心目标
证券之星 · 03-11
四川双马：公司高度重视市值管理工作，始终将提升内在价值作为核心目标
股市必读：四川双马（000935）2月26日董秘有最新回复
证券之星 · 02-27
股市必读：四川双马（000935）2月26日董秘有最新回复
四川双马：持续推进生物医药板块的深度布局与高质量发展
证券之星 · 02-26
四川双马：持续推进生物医药板块的深度布局与高质量发展
2月5日四川双马现2笔大宗交易 机构净买入5499.45万元
证券之星 · 02-05
2月5日四川双马现2笔大宗交易 机构净买入5499.45万元
四川双马：近年完成对深圳健元的收购
证券之星 · 02-03
四川双马：近年完成对深圳健元的收购
四川双马：本次股份转让的转让方为境外主体，需要准备合规确认的申请资料
证券之星 · 01-30
四川双马：本次股份转让的转让方为境外主体，需要准备合规确认的申请资料
【川股每日董秘问答】涉泸州老窖、四川双马、中密控股、金石亚药、厚普股份等公司
金融投资报 · 01-28
【川股每日董秘问答】涉泸州老窖、四川双马、中密控股、金石亚药、厚普股份等公司
股市必读：四川双马（000935）1月27日董秘有最新回复
证券之星 · 01-28
股市必读：四川双马（000935）1月27日董秘有最新回复
四川双马：深圳健元生产的美容肽原料、高附加值的复配液体美容肽产品共计百余种
证券之星 · 01-27
四川双马：深圳健元生产的美容肽原料、高附加值的复配液体美容肽产品共计百余种
四川双马：产品远销美国、巴西、印度、西班牙等国际市场
证券之星 · 01-27
四川双马：产品远销美国、巴西、印度、西班牙等国际市场
四川双马：专注于生物医药领域创新药孵化
证券之星 · 01-27
四川双马：专注于生物医药领域创新药孵化
加载更多
公司概况
公司名称：
四川和谐双马股份有限公司
所属行业：
非金属矿物制品业
上市日期：
1999-08-24
主营业务：
四川和谐双马股份有限公司的主营业务是生物医药研发生产企业、建材生产制造企业的产业投资及管理，和私募股权投资基金管理。公司的主要产品是多肽类产品、水泥、骨料、私募股权投资基金管理。公司2025年荣获“全国第二十次水泥品质指标检验大对比全优奖”。
发行价格：
4.50
{"stockData":{"symbol":"000935","market":"SZ","secType":"STK","nameCN":"四川双马","latestPrice":28.5,"timestamp":1778223789000,"preClose":28.4,"halted":0,"volume":6581305,"delay":0,"changeRate":0.0035,"floatShares":763000000,"shares":763000000,"eps":0.3151,"marketStatus":"已收盘","change":0.1,"latestTime":"05-08 15:00:00","open":28.44,"high":29,"low":27.96,"amount":186000000,"amplitude":0.0366,"askPrice":28.54,"askSize":7,"bidPrice":28.5,"bidSize":403,"shortable":0,"etf":0,"ttmEps":0.3151,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778463000000},"marketStatusCode":5,"adr":0,"adjPreClose":28.4,"symbolType":"stock","openAndCloseTimeList":[[1778203800000,1778211000000],[1778216400000,1778223600000]],"highLimit":31.24,"lowLimit":25.56,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":763440333,"isCdr":false,"pbRate":2.77,"roa":"--","peRate":90.447477,"roe":"0.75%","epsLYR":0.39,"committee":0.087968,"marketValue":21758000000,"turnoverRate":0.0086,"status":0,"floatMarketCap":21758000000},"requestUrl":"/m/hq/s/000935","defaultTab":"news","newsList":[{"id":"2633488136","title":"四川双马：公司连续流加氢技术平台正建设中","url":"https://stock-news.laohu8.com/highlight/detail?id=2633488136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633488136?lang=zh_cn&edition=full","pubTime":"2026-05-08 11:33","pubTimestamp":1778211208,"startTime":"0","endTime":"0","summary":"证券之星消息，四川双马(000935)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：3. 氮杂环丁烷小环结构是抗癌、神经、抗病毒创新药的核心骨架，请问贵公司在该类高难度小环中间体领域，是否有布局连续流加氢、电催化等绿色工艺？目前有没有已落地的商业化项目？四川双马回复：您好，公司连续流加氢技术平台正建设中，目前已有相关项目在推进，但暂未涉及氮杂环丁烷小环结构相关品类。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。相关 ETF","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800017070.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","000935","BK0028","BK0004","BK0021"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630258320","title":"四川双马（000935）披露2025年年度报告，4月28日股价下跌1.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630258320","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630258320?lang=zh_cn&edition=full","pubTime":"2026-04-28 22:13","pubTimestamp":1777385586,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，四川双马报收于28.09元，较前一交易日下跌1.85%，最新总市值为214.45亿元。该股当日开盘28.68元，最高28.7元，最低27.83元，成交额达1.9亿元，换手率为0.89%。近日，四川双马披露《2025年年度报告》。2025年营业收入为1,205,510,116.01元，同比增长12.19%；归属于上市公司股东的净利润为298,276,450.60元，同比下降3.59%；扣除非经常性损益后的净利润为341,533,816.21元，同比大幅增长464.24%。经营活动产生的现金流量净额为321,501,858.70元，同比下降30.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800064615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0235","000935","BK0021","BK0004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630737232","title":"四川双马(000935.SZ)发布一季度业绩，归母净利润5879.61万元，同比下降49.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630737232","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630737232?lang=zh_cn&edition=full","pubTime":"2026-04-28 17:51","pubTimestamp":1777369918,"startTime":"0","endTime":"0","summary":"智通财经APP讯，四川双马(000935.SZ)发布2026年第一季度报告，第一季度，公司实现营业收入2.67亿元，同比下降17.70%。归属于上市公司股东的净利润5879.61万元，同比下降49.55%。归属于上市公司股东的扣除非经常性损益的净利润5778.16万元，同比下降49.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"530716c61aaa22cfcffdb04a123fa588","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000935"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628795501","title":"股市必读：四川双马（000935）4月17日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2628795501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628795501?lang=zh_cn&edition=full","pubTime":"2026-04-20 03:54","pubTimestamp":1776628449,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘，四川双马报收于27.38元，上涨0.29%，换手率0.63%，成交量4.81万手，成交额1.33亿元。董秘最新回复投资者： 公司能否发个一季报预告？当日关注点来自交易信息汇总：4月17日主力资金净流入778.97万元，显示主力对个股短期关注度提升。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000001266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0004","000935","BK0235","BK0021","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623334242","title":"国金证券：给予四川双马买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2623334242","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623334242?lang=zh_cn&edition=full","pubTime":"2026-03-29 11:25","pubTimestamp":1774754718,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司舒思勤,洪希柠,方丽近期对四川双马进行研究并发布了研究报告《基金进入收获期，多肽CDMO促增长》，给予四川双马买入评级。 1、基础盘与安全边际：私募股权业务进入收获期，提供业绩支撑与现金流。当前市值尚未充分反映医药板块的成长潜力及两大业务的协同价值，存在价值重估空间。最新盈利预测明细如下：该股最近90天内共有2家机构给出评级，买入评级2家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900002030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000935"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622893114","title":"股市必读：3月26日四川双马发生1笔大宗交易 成交金额1896.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622893114","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622893114?lang=zh_cn&edition=full","pubTime":"2026-03-27 02:47","pubTimestamp":1774550830,"startTime":"0","endTime":"0","summary":"截至2026年3月26日收盘，四川双马报收于24.35元，下跌2.76%，换手率0.56%，成交量4.3万手，成交额1.06亿元。交易信息汇总资金流向3月26日主力资金净流入251.67万元；游资资金净流入231.33万元；散户资金净流出483.0万元。大宗交易3月26日四川双马发生1笔大宗交易，成交金额1896.04万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700004492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0021","BK0235","000935","BK0004","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622946025","title":"3月25日四川双马涨5.83%，华夏价值精选混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622946025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622946025?lang=zh_cn&edition=full","pubTime":"2026-03-25 16:24","pubTimestamp":1774427044,"startTime":"0","endTime":"0","summary":"证券之星消息，3月25日四川双马涨5.83%，收盘报25.04元，换手率0.93%，成交量7.11万手，成交额1.76亿元。重仓四川双马的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为华夏基金的华夏价值精选混合A。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500030458.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","000935","BK0028","BK0004","BK0021"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621177610","title":"3月23日四川双马跌5.83%，华夏价值精选混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621177610","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621177610?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:47","pubTimestamp":1774255640,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日四川双马跌5.83%创60日新低，收盘报23.09元，换手率0.84%，成交量6.44万手，成交额1.51亿元。重仓四川双马的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为华夏基金的华夏价值精选混合A。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0235","BK0021","BK0004","000935"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620182362","title":"四川双马：本次股份转让正在按程序推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2620182362","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620182362?lang=zh_cn&edition=full","pubTime":"2026-03-19 11:36","pubTimestamp":1773891402,"startTime":"0","endTime":"0","summary":"证券之星消息，四川双马(000935)03月18日在投资者关系平台上答复投资者关心的问题。投资者提问：几个月了，公司股权转让还没进展？四川双马回复：您好，本次股份转让正在按程序推进中。公司将密切跟进该事项的进展，及时披露进展情况。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900015409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000935","BK0004","BK0235","BK0021"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618992804","title":"四川双马：公司高度重视市值管理工作，始终将提升内在价值作为核心目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2618992804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618992804?lang=zh_cn&edition=full","pubTime":"2026-03-11 11:36","pubTimestamp":1773200210,"startTime":"0","endTime":"0","summary":"证券之星消息，四川双马(000935)03月10日在投资者关系平台上答复投资者关心的问题。投资者提问：公司市值还不如公司管理私募基金市值多，公司市值管理的目标是多少？四川双马回复：您好，公司高度重视市值管理工作，始终将提升内在价值作为核心目标。公司坚持以稳健经营与业绩成长为基石，优化业务布局，强化核心竞争力，提升发展质量；同时，不断完善公司治理，规范信息披露，加强投资者关系管理，持续推动公司价值被市场充分认可与合理体现。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100016775.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0021","BK0028","BK0235","BK0004","000935"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614272940","title":"股市必读：四川双马（000935）2月26日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2614272940","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614272940?lang=zh_cn&edition=full","pubTime":"2026-02-27 02:26","pubTimestamp":1772130373,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘，四川双马报收于28.6元，上涨0.7%，换手率0.74%，成交量5.67万手，成交额1.62亿元。董秘最新回复投资者： 进入农历马年，公司有什么展望？","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700001314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000935","BK0004","BK0235","BK0021"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614501352","title":"四川双马：持续推进生物医药板块的深度布局与高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2614501352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614501352?lang=zh_cn&edition=full","pubTime":"2026-02-26 16:33","pubTimestamp":1772094795,"startTime":"0","endTime":"0","summary":"四川双马回复：您好，近年来，公司业务已基本成型，形成了以投资带产业的发展模式，基金投资布局科创领域、战略新兴产业等，并通过直投和投资孵化器平台的方式布局了生物医药等科创领域，进一步优化业务布局，拓宽发展空间，整体经营活力与发展潜力持续提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600024275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399441","BK0028","BK0235","000935","BK0021","BK0004","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609119320","title":"2月5日四川双马现2笔大宗交易 机构净买入5499.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609119320","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609119320?lang=zh_cn&edition=full","pubTime":"2026-02-05 17:26","pubTimestamp":1770283615,"startTime":"0","endTime":"0","summary":"证券之星消息，2月5日四川双马发生大宗交易，交易数据如下：近三个月该股共发生19笔大宗交易，合计成交10.41万手，折价成交19笔。该股近期无解禁股上市。截至2026年2月5日收盘，四川双马(000935)报收于27.7元，下跌0.18%，换手率0.69%，成交量5.25万手，成交额1.46亿元。该股近半年内有股东持股变动，合计净减持3274.33万股，股东增减持明细如下表：该股最近90天内共有1家机构给出评级，买入评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500027959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","BK0021","BK0028","BK0004","000935"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608843423","title":"四川双马：近年完成对深圳健元的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2608843423","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608843423?lang=zh_cn&edition=full","pubTime":"2026-02-03 11:34","pubTimestamp":1770089670,"startTime":"0","endTime":"0","summary":"证券之星消息，四川双马(000935)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：公司总说价值回报投资者，连个年报预告都发不出来，如何回报？四川双马回复：您好，公司近年完成了对生物医药企业深圳健元的收购，进一步拓展了公司未来发展板块，经营发展活力进一步增强。未来公司将在夯实投资板块的同时持续推动生物医药业务的深入发展，不断提升运营效能，努力为股东创造更多价值与回报，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300016162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000935","BK0028","BK0235","BK0004","BK0021"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607063243","title":"四川双马：本次股份转让的转让方为境外主体，需要准备合规确认的申请资料","url":"https://stock-news.laohu8.com/highlight/detail?id=2607063243","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607063243?lang=zh_cn&edition=full","pubTime":"2026-01-30 09:01","pubTimestamp":1769734860,"startTime":"0","endTime":"0","summary":"证券之星消息，四川双马01月29日在投资者关系平台上答复投资者关心的问题。公司将持续关注相关事项的进展，及时披露进展情况，请持续关注公司公告，感谢您对公司的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026013000007948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000935","BK0028","BK0235","BK0004","BK0021"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606921767","title":"【川股每日董秘问答】涉泸州老窖、四川双马、中密控股、金石亚药、厚普股份等公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2606921767","media":"金融投资报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606921767?lang=zh_cn&edition=full","pubTime":"2026-01-28 18:00","pubTimestamp":1769594400,"startTime":"0","endTime":"0","summary":"公司产品目前未涉及到6G网络业务中。未来若有达到法定信息披露标准的进展事项，公司将严格按照相关规定及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-01-28/doc-inhiwhqw3816161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0235","LU0052750758.USD","IE0005HP3H50.USD","BK0175","BK0012","BK0028","BK0132","BK0025","BK1610","LU1064131003.USD","LU0708995583.HKD","300471","000935","LU1997245177.USD","LU0320764599.SGD","LU0348805143.USD","300434","BK0188","BK0183","03189","LU1997245094.SGD","BK0215","300470","BK0187","BK0239","LU1781817850.SGD","LU1580142542.USD","BK0021","BK0156","BK0259","LU1655091616.SGD","BK0004","000568","BK0017","LU1064130708.USD","BK0196","83189","BK0077","BK0119","LU2148510915.USD","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606873456","title":"股市必读：四川双马（000935）1月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606873456","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606873456?lang=zh_cn&edition=full","pubTime":"2026-01-28 02:02","pubTimestamp":1769536939,"startTime":"0","endTime":"0","summary":"截至2026年1月27日收盘，四川双马报收于27.13元，上涨0.26%，换手率0.96%，成交量7.3万手，成交额1.96亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800001202.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0235","BK0004","BK0021","000935","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606422040","title":"四川双马：深圳健元生产的美容肽原料、高附加值的复配液体美容肽产品共计百余种","url":"https://stock-news.laohu8.com/highlight/detail?id=2606422040","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606422040?lang=zh_cn&edition=full","pubTime":"2026-01-27 08:45","pubTimestamp":1769474712,"startTime":"0","endTime":"0","summary":"证券之星消息，四川双马(000935)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：问，贵司生产的美容肰品种有上百种？供应哪些大品牌化妆品厂家？请董秘详答。四川双马回复：您好，在美容肽业务方面，深圳健元生产的美容肽原料、高附加值的复配液体美容肽产品共计百余种，公司已与多家全球头部化妆品企业建立并保持稳固的战略合作关系，产品应用于其高端护肤系列，有力支撑客户产品创新与市场竞争力提升。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700007830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000935","BK0235","BK0021","BK0028","BK0004"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606220268","title":"四川双马：产品远销美国、巴西、印度、西班牙等国际市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2606220268","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606220268?lang=zh_cn&edition=full","pubTime":"2026-01-27 08:45","pubTimestamp":1769474712,"startTime":"0","endTime":"0","summary":"四川双马回复：您好，在多肽原料药方面，深圳健元围绕重大慢性疾病领域，布局了包括司美格鲁肽、利拉鲁肽、替尔泊肽在内的多个品种，技术储备深厚；公司核心原料药品种已成功通过中国、美国、欧洲、韩国等多国注册备案，具备强大的全球化供应能力，是国内少数拥有大规模、高合规标准生产能力的领先供应商之一，产品远销美国、巴西、印度、西班牙等国际市场。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700007829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159100","BK0021","BK0004","000935","BK0028","MNDmain","BK0235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606220429","title":"四川双马：专注于生物医药领域创新药孵化","url":"https://stock-news.laohu8.com/highlight/detail?id=2606220429","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606220429?lang=zh_cn&edition=full","pubTime":"2026-01-27 08:42","pubTimestamp":1769474535,"startTime":"0","endTime":"0","summary":"证券之星消息，四川双马(000935)01月26日在投资者关系平台上答复投资者关心的问题。投资者提问：问，四川双马是否有产品涉及到创新药？请董秘详答。谢谢四川双马回复：您好，公司以直投和投资孵化器平台的方式布局生物医药等科创领域，专注于生物医药领域创新药孵化，目前已在肿瘤、自身免疫、代谢、神经系统疾病等多个疾病领域，集中布局了一批处于早期阶段、产品数据具备国际竞争力的创新药企业，并采用体系化、平台化的孵化模式推动成果转化。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700007815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399441","06978","BK0028","161726","BK1161","BK1574","BK0235","BK0004","159992","BK0021","000935"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778449525387,"stockEarnings":[{"period":"1week","weight":0.0666},{"period":"1month","weight":0.115},{"period":"3month","weight":0.0474},{"period":"6month","weight":0.4039},{"period":"1year","weight":0.7625},{"period":"ytd","weight":0.1473}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0281},{"period":"6month","weight":0.0456},{"period":"1year","weight":0.247},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"四川和谐双马股份有限公司","boardCode":"AI0030","boardName":"非金属矿物制品业","stockholders":"20497人(较上一季度减少17.75%)","perCapita":"37246股","listingDate":"1999-08-24","address":"四川省绵阳市江油市二郎庙镇","registeredCapital":"76344万元","survey":" 四川和谐双马股份有限公司的主营业务是生物医药研发生产企业、建材生产制造企业的产业投资及管理，和私募股权投资基金管理。公司的主要产品是多肽类产品、水泥、骨料、私募股权投资基金管理。公司2025年荣获“全国第二十次水泥品质指标检验大对比全优奖”。","listedPrice":4.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"四川双马(000935)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供四川双马(000935)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"四川双马,000935,四川双马股票,四川双马股票老虎,四川双马股票老虎国际,四川双马行情,四川双马股票行情,四川双马股价,四川双马股市,四川双马股票价格,四川双马股票交易,四川双马股票购买,四川双马股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"四川双马(000935)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供四川双马(000935)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}